Predictions
Esker S.A.
Start price
Target price
Perf. (%)
€342.00
15.11.21
15.11.21
€340.00
15.11.22
15.11.22
-25.15%
02.02.22
02.02.22
Could be worthwhile Investment >10% per year
Artprice.com
Start price
Target price
Perf. (%)
€21.65
15.11.21
15.11.21
-
15.11.22
15.11.22
-22.68%
18.11.21
18.11.21
Probably not worthwhile Investment
Artprice.com
Start price
Target price
Perf. (%)
€19.68
15.11.21
15.11.21
-
15.11.22
15.11.22
-32.83%
26.11.21
26.11.21
Risky Investment
Linedata Services
Start price
Target price
Perf. (%)
€38.20
07.11.21
07.11.21
€43.00
07.11.22
07.11.22
20.94%
08.11.22
08.11.22
Could be worthwhile Investment >10% per year
Mediantechnologies
Start price
Target price
Perf. (%)
€17.20
26.10.21
26.10.21
-
26.10.22
26.10.22
-9.88%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Groupe SFPI S.A.
Start price
Target price
Perf. (%)
€3.45
24.10.21
24.10.21
€2.90
24.10.22
24.10.22
-38.61%
22.10.22
22.10.22
Could be worthwhile Investment >10% per year
It Link S.A.
Start price
Target price
Perf. (%)
€31.00
18.10.21
18.10.21
€24.00
18.10.22
18.10.22
-11.29%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Pharmagest Interactive S.A.
Start price
Target price
Perf. (%)
€95.40
04.10.21
04.10.21
€98.00
04.11.21
04.11.21
3.25%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Esker S.A.
Start price
Target price
Perf. (%)
€285.00
17.09.21
17.09.21
€285.00
17.09.22
17.09.22
20.00%
15.11.21
15.11.21
Could be worthwhile Investment >10% per year
Pharmagest Interactive S.A.
Start price
Target price
Perf. (%)
€97.20
07.09.21
07.09.21
€90.00
04.11.21
04.11.21
-1.85%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
Groupe Open
Start price
Target price
Perf. (%)
€19.15
07.09.21
07.09.21
€17.00
07.09.22
07.09.22
24.80%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Alten S.A.
Start price
Target price
Perf. (%)
€133.10
29.07.21
29.07.21
€126.00
29.07.22
29.07.22
-1.50%
30.07.22
30.07.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected